About
Tumor Screening Platform
Areas of Focus
Categories
Non-PharmaceuticalSoutheastern U.S.
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
50
By Phase
EARLY_PHASE1: 1
By Status
RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05332925Collaborator
Using Ex Vivo Tumoroids To Predict Immunotherapy Response In NSCLC
N/ARecruiting
25 participants
Started: Jul 21, 2022 · Completed: Feb 28, 2027
NCT03371992Lead Sponsor
Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC
EARLY_PHASE1Unknown
25 participants
Started: Mar 9, 2018 · Completed: Jun 30, 2021
Locations (1)
Headquarters
Tampa, FL, United States
Map
Loading map...